REFERENCES
1. Mylotte D, Osnabrugge RL, Windecker S, et al. Transcatheter
aortic valve replacement in Europe:adoption trends and factors
influencing device utilization. J Am CollCardiol 2013;62:210-9.
2. Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve
replacement for degenerative bioprosthetic surgical valves: results from
the global valve-in-valve registry. Circulation 2012;126:2335-44.
3. Phan K, Tsai YC, Niranjan N, et al. Sutureless aortic valve
replacement: a systematic review and meta-analysis. Ann CardiothoracSurg
2015;4:100-11.
4. Fischlein T, Meuris B, Hakim-Meibodi K, et al. The sutureless
aortic valve at 1 year: a large multicenter cohort study. J
ThoracCardiovascSurg 2016;151:1617–26.
5. Di Eusanio M, Saia F, Pellicciari G, et al. In the era of
the valve-in-valve: is transcatheter aortic valve implantation (TAVI) in
sutureless valves feasible? Ann Cardiothorac Surg. 2015 Mar;4(2):214-7.
6. Gurvitch R, Cheung A, Ye J, et al: Transcatheter
valve-in-valve implantation
for failed surgical bioprosthetic valves. J Am CollCardiol
58:2196–2209, 2011.
7. Attia R, Papalexopoulou N, Hancock J, et al. Successful
treatment of failing biological prosthesis due to ‘stent creep’ with
Valve-in-Valve Transcatheter Aortic Valve Implantation.
Catheter CardiovascInterv 2014.
8. Mangner N, Holzhey D, Misfeld M, et al.Treatment of a
degenerated sutureless Sorin Perceval® valve using an Edwards SAPIEN
3.Interact CardiovascThorac Surg. 2018 Feb 1;26(2):364-366.